NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ASTH Stock Alerts $37.46 +0.39 (+1.05%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$36.78▼$38.1850-Day Range$36.56▼$45.0452-Week Range$28.86▼$45.71Volume106,977 shsAverage Volume106,090 shsMarket Capitalization$2.10 billionP/E Ratio28.38Dividend YieldN/APrice Target$47.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsSocial Media Get Astrana Health alerts: Email Address Astrana Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside25.5% Upside$47.00 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth16.67%From $1.62 to $1.89 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.38 out of 5 starsMedical Sector2941st out of 5,424 stocksManagement Consulting Services Industry67th out of 96 stocks 3.3 Analyst's Opinion Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAstrana Health has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for ASTH. Previous Next 0.0 Dividend Strength Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ASTH. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 5 news articles for Astrana Health this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for ASTH on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Astrana Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.46% of the stock of Astrana Health is held by insiders.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Astrana Health are expected to grow by 16.67% in the coming year, from $1.62 to $1.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 28.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.52.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 28.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 202.33.Price to Earnings Growth RatioAstrana Health has a PEG Ratio of 1.21. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 3.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Astrana Health Stock (NASDAQ:ASTH)Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Read More ASTH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ASTH Stock News HeadlinesMay 3, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Astrana Health (ASTH)April 30, 2024 | prnewswire.comAstrana Health, Inc. Schedules 2024 First Quarter Financial Results Release and Conference CallMay 4, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 28, 2024 | seekingalpha.comASTH Astrana Health, Inc.April 28, 2024 | nasdaq.comCommit To Purchase Astrana Health At $25, Earn 6.5% Annualized Using OptionsApril 24, 2024 | investing.comAstrana Health Inc (ASTH)April 21, 2024 | finance.yahoo.comInvestors Could Be Concerned With Astrana Health's (NASDAQ:ASTH) Returns On CapitalApril 11, 2024 | barrons.comAstrana Health Inc.May 4, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.April 4, 2024 | finance.yahoo.comAstrana Health, Inc. (NASDAQ:ASTH) Shares Could Be 50% Below Their Intrinsic Value EstimateApril 2, 2024 | stockhouse.comAstrana Health, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)April 2, 2024 | prnewswire.comAstrana Health, Inc. Completes Acquisition of Community Family Care Medical Group IPA, Inc. and Health PlanMarch 21, 2024 | finance.yahoo.comAstrana Health, Inc.'s (NASDAQ:ASTH) Stock Is Going Strong: Is the Market Following Fundamentals?March 18, 2024 | yahoo.comWidely Used Inhalers Won't Cost More Than $35 a Month, AstraZeneca SaysMarch 16, 2024 | morningstar.comAstrana Health Inc ASTHMarch 15, 2024 | msn.comWhat Is Allergic Asthma?March 14, 2024 | msn.comAsk A Doctor: What Are The Complications Of Asthma?March 14, 2024 | theguardian.comSolidarity and strategy: the forgotten lessons of truly effective protestMarch 6, 2024 | nasdaq.comAstrana Health Inc. Rings the Closing BellMarch 1, 2024 | prnewswire.comAstrana Health, Inc. to Participate in Upcoming Investor ConferenceFebruary 27, 2024 | prnewswire.comAstrana Health, Inc. Reports Fourth Quarter and Year-End 2023 ResultsSee More Headlines Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today5/04/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Management consulting services Sub-IndustryN/A Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CUSIPN/A CIK1083446 Webwww.apollomed.net Phone626-282-0288Fax818-839-5190Employees1,800Year FoundedN/APrice Target and Rating Average Stock Price Target$47.00 High Stock Price Target$50.00 Low Stock Price Target$44.00 Potential Upside/Downside+25.5%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$1.32 Trailing P/E Ratio28.38 Forward P/E Ratio23.12 P/E Growth1.21Net Income$60.72 million Net Margins4.49% Pretax Margin6.48% Return on Equity11.52% Return on Assets6.67% Debt Debt-to-Equity Ratio0.42 Current Ratio2.11 Quick Ratio2.11 Sales & Book Value Annual Sales$1.39 billion Price / Sales1.51 Cash Flow$1.38 per share Price / Cash Flow27.17 Book Value$10.58 per share Price / Book3.54Miscellaneous Outstanding Shares56,030,000Free Float51,286,000Market Cap$2.10 billion OptionableOptionable Beta1.12 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Kenneth T. Sim M.D. (Age 69)Co-Founder & Executive Chairman Comp: $1.49MMr. Brandon K. Sim M.S. (Age 30)President & CEO Comp: $1.73MDr. Thomas S. Lam M.D. (Age 75)M.P.H., Co-Founder & Vice Chairman Comp: $1.49MMr. Chandan Basho M.B.A. (Age 41)CFO & COO Comp: $581.42kDr. WaiChow Young M.D. (Age 76)M.P.H., Chief Administrative Officer Comp: $573.67kMr. John Vong CPA (Age 51)CGMA, M.B.A., Chief Accounting Officer Ms. Rita Pew M.B.A.Vice President of People & OperationsDr. Jeremy R. Jackson M.D.Chief Quality OfficerMr. Neil AhujaPresident of Provider SolutionsDr. Carlos Palacios M.D.Chief Medical Officer for TexasMore ExecutivesKey Competitorsagilon healthNYSE:AGLKymera TherapeuticsNASDAQ:KYMRGeronNASDAQ:GERNTG TherapeuticsNASDAQ:TGTXCelldex TherapeuticsNASDAQ:CLDXView All Competitors ASTH Stock Analysis - Frequently Asked Questions Should I buy or sell Astrana Health stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Astrana Health in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ASTH shares. View ASTH analyst ratings or view top-rated stocks. What is Astrana Health's stock price target for 2024? 2 brokerages have issued 12 month target prices for Astrana Health's stock. Their ASTH share price targets range from $44.00 to $50.00. On average, they expect the company's stock price to reach $47.00 in the next year. This suggests a possible upside of 25.5% from the stock's current price. View analysts price targets for ASTH or view top-rated stocks among Wall Street analysts. How have ASTH shares performed in 2024? Astrana Health's stock was trading at $42.79 on January 1st, 2024. Since then, ASTH shares have decreased by 12.5% and is now trading at $37.46. View the best growth stocks for 2024 here. When is Astrana Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our ASTH earnings forecast. How can I listen to Astrana Health's earnings call? Astrana Health will be holding an earnings conference call on Tuesday, May 7th at 5:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) announced its earnings results on Tuesday, February, 27th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.17 by $0.09. The company had revenue of $353 million for the quarter, compared to analysts' expectations of $341.17 million. Astrana Health had a trailing twelve-month return on equity of 11.52% and a net margin of 4.49%. The firm's quarterly revenue was up 20.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.02 EPS. What ETFs hold Astrana Health's stock? ETFs with the largest weight of Astrana Health (NASDAQ:ASTH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH) and Syntax Stratified SmallCap ETF (SSLY).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Astrana Health issued on next quarter's earnings? Astrana Health updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of 1.280-1.520 for the period, compared to the consensus EPS estimate of 1.520. The company issued revenue guidance of $1.7 billion-$1.9 billion, compared to the consensus revenue estimate of $1.7 billion. How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ASTH) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe only defense company you should be looking atBehind the MarketsThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
